Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1953 3
1954 2
1955 7
1956 3
1957 1
1958 3
1959 2
1960 5
1961 1
1962 4
1964 1
1965 2
1966 4
1967 2
1968 3
1969 1
1970 7
1971 5
1972 2
1973 3
1974 5
1975 6
1977 3
1979 5
1980 1
1982 2
1983 1
1984 2
1987 2
1990 1
1991 1
1992 2
1994 1
2001 3
2002 2
2003 2
2004 3
2005 4
2006 7
2007 9
2008 4
2009 4
2010 3
2011 2
2012 9
2013 8
2014 7
2015 8
2016 11
2017 1
2018 5
2019 2
2020 6
2021 5
2022 11
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Results by year

Filters applied: . Clear all
Page 1
Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.
Valerio L, Mavromanoli AC, Barco S, Abele C, Becker D, Bruch L, Ewert R, Faehling M, Fistera D, Gerhardt F, Ghofrani HA, Grgic A, Grünig E, Halank M, Held M, Hobohm L, Hoeper MM, Klok FA, Lankeit M, Leuchte HH, Martin N, Mayer E, Meyer FJ, Neurohr C, Opitz C, Schmidt KH, Seyfarth HJ, Wachter R, Wilkens H, Wild PS, Konstantinides SV, Rosenkranz S; FOCUS Investigators. Valerio L, et al. Among authors: seyfarth hj. Eur Heart J. 2022 Sep 21;43(36):3387-3398. doi: 10.1093/eurheartj/ehac206. Eur Heart J. 2022. PMID: 35484821 Free PMC article.
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension.
Hoeper MM, Pausch C, Olsson KM, Huscher D, Pittrow D, Grünig E, Staehler G, Vizza CD, Gall H, Distler O, Opitz C, Gibbs JSR, Delcroix M, Ghofrani HA, Park DH, Ewert R, Kaemmerer H, Kabitz HJ, Skowasch D, Behr J, Milger K, Halank M, Wilkens H, Seyfarth HJ, Held M, Dumitrescu D, Tsangaris I, Vonk-Noordegraaf A, Ulrich S, Klose H, Claussen M, Lange TJ, Rosenkranz S. Hoeper MM, et al. Among authors: seyfarth hj. Eur Respir J. 2022 Jul 7;60(1):2102311. doi: 10.1183/13993003.02311-2021. Print 2022 Jul. Eur Respir J. 2022. PMID: 34737226 Free PMC article.
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis.
Hoeper MM, Dwivedi K, Pausch C, Lewis RA, Olsson KM, Huscher D, Pittrow D, Grünig E, Staehler G, Vizza CD, Gall H, Distler O, Opitz C, Gibbs JSR, Delcroix M, Park DH, Ghofrani HA, Ewert R, Kaemmerer H, Kabitz HJ, Skowasch D, Behr J, Milger K, Lange TJ, Wilkens H, Seyfarth HJ, Held M, Dumitrescu D, Tsangaris I, Vonk-Noordegraaf A, Ulrich S, Klose H, Claussen M, Eisenmann S, Schmidt KH, Swift AJ, Thompson AAR, Elliot CA, Rosenkranz S, Condliffe R, Kiely DG, Halank M. Hoeper MM, et al. Among authors: seyfarth hj. Lancet Respir Med. 2022 Oct;10(10):937-948. doi: 10.1016/S2213-2600(22)00097-2. Epub 2022 Jun 28. Lancet Respir Med. 2022. PMID: 35777416 Free PMC article.
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis.
Rosenkranz S, Pausch C, Coghlan JG, Huscher D, Pittrow D, Grünig E, Staehler G, Vizza CD, Gall H, Distler O, Delcroix M, Ghofrani HA, Ewert R, Kabitz HJ, Skowasch D, Behr J, Milger K, Halank M, Wilkens H, Seyfarth HJ, Held M, Scelsi L, Neurohr C, Vonk-Noordegraaf A, Ulrich S, Klose H, Claussen M, Eisenmann S, Schmidt KH, Remppis BA, Skride A, Jureviciene E, Gumbiene L, Miliauskas S, Löffler-Ragg J, Lange TJ, Olsson KM, Hoeper MM, Opitz C. Rosenkranz S, et al. Among authors: seyfarth hj. J Heart Lung Transplant. 2023 Jan;42(1):102-114. doi: 10.1016/j.healun.2022.10.003. Epub 2022 Oct 13. J Heart Lung Transplant. 2023. PMID: 36333206 Free article.
Portopulmonary hypertension.
Halank M, Ewert R, Seyfarth HJ, Hoeffken G. Halank M, et al. Among authors: seyfarth hj. J Gastroenterol. 2006 Sep;41(9):837-47. doi: 10.1007/s00535-006-1879-x. J Gastroenterol. 2006. PMID: 17048047 Review.
Als der Polyp ging, kam Luft.
Frille A, Bräunlich J, Seyfarth HJ, Feisthammel J, Wirtz H. Frille A, et al. Among authors: seyfarth hj. Pneumologie. 2016 Dec;70(12):826-830. doi: 10.1055/s-0036-1596068. Epub 2016 Dec 8. Pneumologie. 2016. PMID: 27931063 Free article. German. No abstract available.
[Chronic thromboembolic pulmonary hypertension].
Guth S, Wilkens H, Halank M, Held M, Hobohm L, Konstantinides S, Omlor A, Seyfarth HJ, Schäfers HJ, Mayer E, Wiedenroth CB. Guth S, et al. Among authors: seyfarth hj. Pneumologie. 2023 Nov;77(11):937-946. doi: 10.1055/a-2145-4807. Epub 2023 Nov 14. Pneumologie. 2023. PMID: 37963483 Free article. German.
Circulating microRNAs predict recurrence and death following venous thromboembolism.
Ten Cate V, Rapp S, Schulz A, Pallares Robles A, Jurk K, Koeck T, Espinola-Klein C, Halank M, Seyfarth HJ, Beutel ME, Schuster AK, Marini F, Hobohm L, Lankeit M, Lackner KJ, Ruf W, Münzel T, Andrade-Navarro MA, Prochaska JH, Konstantinides SV, Wild PS. Ten Cate V, et al. Among authors: seyfarth hj. J Thromb Haemost. 2023 Oct;21(10):2797-2810. doi: 10.1016/j.jtha.2023.07.010. Epub 2023 Jul 20. J Thromb Haemost. 2023. PMID: 37481073 Free article.
Association of FXI activity with thrombo-inflammation, extracellular matrix, lipid metabolism and apoptosis in venous thrombosis.
Pallares Robles A, Ten Cate V, Schulz A, Prochaska JH, Rapp S, Koeck T, Panova-Noeva M, Heitmeier S, Schwers S, Leineweber K, Seyfarth HJ, Opitz CF, Spronk H, Espinola-Klein C, Lackner KJ, Münzel T, Andrade-Navarro MA, Konstantinides SV, Ten Cate H, Wild PS. Pallares Robles A, et al. Among authors: seyfarth hj. Sci Rep. 2022 Jun 13;12(1):9761. doi: 10.1038/s41598-022-13174-5. Sci Rep. 2022. PMID: 35697739 Free PMC article.
209 results